Stimulation Combined With Powered Motorized Orthoses for Walking After Stroke

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Nov 1, 2026 → Nov 1, 2027
See other at-risk trials from VA Office of Research and Development

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Nov 1, 2026 to Nov 1, 2027
    • Eligibility criteria expanded, about 29 words
    • Secondary endpoints: details revised at 16 of 24 entries
  2. Notable Primary and study completion dates: Nov 1, 2025 to Nov 1, 2026v13
  3. Minor Re-verified, no change to tracked fieldsv12
  4. Notable Primary and study completion dates: Nov 1, 2024 to Nov 1, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 10 to confirmed 5
    • Site details revised
    v11
  5. Notable Primary and study completion dates: Feb 29, 2024 to Nov 1, 2024v10
Show 8 earlier versionsHide 8 earlier versions
  1. Minor Site details revisedv9
  2. Minor 4 versions Re-verified since Sep 10, 2020, no change to tracked fieldsv5-v8
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  4. Notable Start date: Mar 1, 2020 to Apr 1, 2020
    • Site contact updated
    v3
  5. Notable Start date: Jan 1, 2020 to Mar 1, 2020
    • Primary and study completion dates: Dec 31, 2023 to Feb 29, 2024
    • Site contact updated
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Objective: The goal of this study is to implement and test a neuro-mechanical gait assist (NMGA) device to correct walking characterized by muscle weakness, incoordination or excessive tone in Veterans with hemiparesis after stroke that adversely affects their ability to walk, exercise, perform activities of daily living, and participate fully in personal, professional and social roles. Research Plan: A prototype NMGA device will be used to develop a finite state controller (FSC) to coordinate each user's volitional effort with surface muscle stimulation and motorized knee assistance as needed. Brace mounted sensors will be used to develop a gait event detector (GED) which will serve the FSC to advance through the phases of gait or stair climbing. In addition, a rule-base intent detection algorithm will be developed using brace mounted sensors and user interface input to select among various functions including walking, stairs climbing, sit-to-stand and stand-to-sit maneuvers. The FSC controller tuning and intent algorithm development and evaluation will be on pilot subjects with difficulty walking after stroke. Outcome measures during development will provide specifications for a new prototype NMGA design which will be evaluated on pilot subjects to test the hypothesis that the NMGA improves walking speed, distance and energy consumption of walking. These baseline data and device will be used to design a follow-up clinical trial to measure orthotic impact of NMGA on mobility in activities of daily living at home and community. Methodology: After meeting inclusion criteria, pilot subjects will undergo baseline gait evaluation with EMG activities of knee flexors and extensors, ankle plantar and dorsiflexors and isokinetic knee strength and passive resistance. They will be fitted with a NMGA combining a knee-ankle-foot-orthosis with a motorized knee joint and surface neuromuscular stimulation of plantar- and dorsi- flexors, vasti and rectus femoris. Brace mounted sensor data will be used for gait event detector (GED) algorithm development and evaluation. The GED will serve the FSC to proceed through phases of gait based on supervisory rule-based user intent recognition algorithm detected by brace mounted sensors and user input interface. The FSC will coordinate feed-forward control of tuned stimulation patterns and closed-loop controlled knee power assist as needed to control foot clearance during swing and stability of the knee during stance. Based on data attained during controller development and evaluation, a new prototype NMGA will be design, constructed and evaluated on pilot subjects to test the hypothesis that a NMGA device improves safety and stability, increases walking speed and distance and minimizes user effort. Clinical Significance: The anticipated outcome is improved gait stability with improved swing knee flexion, thus, increasing the safety and preventing injurious falls of ambulatory individuals with hemiplegia due to stroke found in large and ever-increasing numbers in the aging Veteran population. Correcting gait should lead to improved quality of life and participation.
Trial Details
NCT Number NCT04116671
Lead Sponsor VA Office of Research and Development
Conditions
(from sponsor)
Stroke, Hemiparesis
Related terms Paresis, Stroke
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov